Evidence map›Paper›PMID 36829957›Full record

ReviewAntioxidants (Basel, Switzerland)2023

Biofloc Technology in Fish Aquaculture: A Review.

Young-Bin Yu, Jae-Ho Choi, Ju-Hyeong Lee, A-Hyun Jo, Kyung Mi Lee, Jun-Hwan Kim

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Feasibility of Rainbow Trout (Animals : an open access journal from MDPI · 2026
    Article
  3. Comparison of Growth and Water Quality in the Cultivation ofAnimals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Fermentation of Plant-Based Feeds withAnimals : an open access journal from MDPI · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Young-Bin YuDepartment of Aquatic Life Medicine, Pukyong National University, Busan 48513, Republic of Korea.
Jae-Ho ChoiDepartment of Aquatic Life Medicine, Pukyong National University, Busan 48513, Republic of Korea.
Ju-Hyeong LeeDepartment of Aquatic Life Medicine, Pukyong National University, Busan 48513, Republic of Korea.
A-Hyun JoDepartment of Aquatic Life and Medical Science, Sun Moon University, Asan-si 31460, Republic of Korea.
Kyung Mi LeeAquaculture Industry Division, West Sea Fisheries Research Institute, National Institute of Fisheries Science, Incheon 22383, Republic of Korea.
Jun-Hwan KimDepartment of Aquatic Life and Medical Science, Sun Moon University, Asan-si 31460, Republic of Korea.ORCID 0000-0003-1602-3752

Funding

Sun Moon University 2022
6 · The paper itself

Abstract

The application of biofloc to fish species has several advantages, including the enhancement of production by increasing growth performance and survival rate and the improvement of fish aquaculture physiological activity. There has been a recent increase in biofloc addition to fish culture, and this review examines changes this causes to the survival and growth rate of fish and its economic feasibility. Physiological activity and disease resistance of biofloc-fed fish is being extensively studied. The hematological parameters and antioxidant and immune responses of fish fed biofloc were reviewed in this study, as well as their disease resistance by testing them for major specific diseases. Standards for effectively applying biofloc to fish aquaculture are also suggested.

Indexed as

antioxidant and immune responsesbioflocdisease resistancegrowth performancehematological parameters

Identifiers

PMID36829957
PMCPMC9952110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.